Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Intangibles (2016 - 2021)

Historic Intangibles for Assembly Biosciences (ASMB) over the last 7 years, with Q3 2021 value amounting to $29.0 million.

  • Assembly Biosciences' Intangibles changed 0.0% to $29.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $29.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $29.0 million for FY2020, which is 0.0% changed from last year.
  • As of Q3 2021, Assembly Biosciences' Intangibles stood at $29.0 million, which was down 0.0% from $29.0 million recorded in Q2 2021.
  • Assembly Biosciences' 5-year Intangibles high stood at $29.0 million for Q1 2017, and its period low was $29.0 million during Q1 2017.
  • Moreover, its 5-year median value for Intangibles was $29.0 million (2017), whereas its average is $29.0 million.
  • The largest annual percentage gain for Assembly Biosciences' Intangibles in the last 5 years was 0.0% (2017), contrasted with its biggest fall of 0.0% (2017).
  • Assembly Biosciences' Intangibles (Quarter) stood at $29.0 million in 2017, then changed by 0.0% to $29.0 million in 2018, then changed by 0.0% to $29.0 million in 2019, then changed by 0.0% to $29.0 million in 2020, then changed by 0.0% to $29.0 million in 2021.
  • Its Intangibles was $29.0 million in Q3 2021, compared to $29.0 million in Q2 2021 and $29.0 million in Q1 2021.